Defining the Appropriate Critical Pathway for the Treatment of Infectious Diseases: Challenging Drug-Resistant Pathogens (Highlights of a Special Roundtable Discussion)

21 June, 2018
toumei image
Results of the Surveillance of Resistance for Gram-Positive and Gram-Negative Organisms
com_clyde_l3 Clyde Thornsberry
MRL Pharmaceutical Services, Brentwood, TN, USA
toumei image
Clinical Relevance of In Vitro Resistance: Respiratory Pathogens and Uropathogens
com_antone Antone A. Medeiros
Division of Infectious Diseases, Brown University School of Medicine, Providence, RI, USA
toumei image
Community-Acquired Pneumonia: Recent Treatment Strategies
com_file Thomas M. File Jr
Department of Internal Medicine, Northeastern Ohio Universities College of Medicine, Rootstown, OH, USA
toumei image
Rhinosinusitis: Recent Treatment Strategies
com_michael Michael D. Poole
Department of Otolaryngology, The University of Texas Houston Medical School, Houston, TX, USA
toumei image
toumei image